O3-FA lowered liver fat content, and gamma-glutamyltransferase (GGT) levels but had no effect on alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in patients with NAFLD/NASH. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.